DE69621521T2 - Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen - Google Patents

Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen

Info

Publication number
DE69621521T2
DE69621521T2 DE69621521T DE69621521T DE69621521T2 DE 69621521 T2 DE69621521 T2 DE 69621521T2 DE 69621521 T DE69621521 T DE 69621521T DE 69621521 T DE69621521 T DE 69621521T DE 69621521 T2 DE69621521 T2 DE 69621521T2
Authority
DE
Germany
Prior art keywords
incorporation
preparation
cyclodextrin derivatives
surfactant systems
hydrophobic molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69621521T
Other languages
English (en)
Other versions
DE69621521D1 (de
Inventor
Florence Djedaini-Pilard
Jing Lin
Bruno Perly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of DE69621521D1 publication Critical patent/DE69621521D1/de
Application granted granted Critical
Publication of DE69621521T2 publication Critical patent/DE69621521T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DE69621521T 1995-06-29 1996-06-27 Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen Expired - Fee Related DE69621521T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507841A FR2736056B1 (fr) 1995-06-29 1995-06-29 Derives de cyclodextrines, leur preparation et leur utilisation pour incorporer des molecules hydrophobes dans des systemes de tensioactifs organises

Publications (2)

Publication Number Publication Date
DE69621521D1 DE69621521D1 (de) 2002-07-11
DE69621521T2 true DE69621521T2 (de) 2003-01-02

Family

ID=9480518

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621521T Expired - Fee Related DE69621521T2 (de) 1995-06-29 1996-06-27 Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen

Country Status (8)

Country Link
US (1) US5821349A (de)
EP (1) EP0751150B1 (de)
JP (1) JPH0912605A (de)
AU (1) AU699482B2 (de)
DE (1) DE69621521T2 (de)
FR (1) FR2736056B1 (de)
HU (1) HUP9601791A3 (de)
ZA (1) ZA965364B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792942B1 (fr) * 1999-04-29 2001-06-08 Commissariat Energie Atomique Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes
WO2001070697A1 (en) * 2000-03-20 2001-09-27 Teva Pharmaceutical Industries Ltd. Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
WO2001083564A1 (en) * 2000-04-28 2001-11-08 University College Dublin Amphiphilic macrocyclic derivatives and their analogues
US6527887B1 (en) 2002-01-18 2003-03-04 Mach I, Inc. Polymeric cyclodextrin nitrate esters
FR2861396B1 (fr) * 2003-10-24 2005-12-16 Commissariat Energie Atomique Derives amphiphiles de cyclodextrines,leur procede de preparation et leurs utilisations
US7851457B2 (en) * 2004-01-29 2010-12-14 Innovative Biologics, Inc. β-Cyclodextrin derivatives
CA2596026A1 (en) * 2005-01-28 2006-08-10 Pinnacle Pharmaceuticals, Inc. .beta.-cyclodextrin derivatives as antibacterial agents
JP5364923B2 (ja) * 2009-01-28 2013-12-11 学校法人福岡大学 多機能性シクロデキストリン誘導体、その包接化合物およびそれらの製造方法。
EP2415464B1 (de) * 2009-03-30 2017-05-10 Eisai R&D Management Co., Ltd. Verfahren zur herstellung einer liposomenzusammensetzung
CN102369008B (zh) 2009-03-30 2014-10-29 卫材R&D管理有限公司 脂质体组合物
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
WO1995015746A1 (en) * 1993-12-10 1995-06-15 The School Of Pharmacy Liposome delivery systems

Also Published As

Publication number Publication date
HUP9601791A2 (en) 1997-05-28
FR2736056B1 (fr) 1997-08-08
AU5616496A (en) 1997-01-09
AU699482B2 (en) 1998-12-03
DE69621521D1 (de) 2002-07-11
ZA965364B (en) 1997-01-23
FR2736056A1 (fr) 1997-01-03
HUP9601791A3 (en) 1997-08-28
EP0751150A1 (de) 1997-01-02
HU9601791D0 (en) 1997-06-30
US5821349A (en) 1998-10-13
JPH0912605A (ja) 1997-01-14
EP0751150B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
NO991942D0 (no) FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende en eller flere biologisk aktive molekyler
DE10299001I1 (de) Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel.
DE59603216D1 (de) Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege
ATE247099T1 (de) Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
ATE224910T1 (de) Derivate von dolestatin, deren herstellung und verwendung
ATE238342T1 (de) Neue thrombin-inhibitoren, deren herstellung und verwendung
DE69711230T2 (de) Biologisch aktive substanzen, verfahren zur herstellung und sie enthaltende zusammensetzungen
DE69715482D1 (de) Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan
DE59711006D1 (de) Emulgatormischungen und deren verwendung zur herstellung von pit-emulsionen
DE69621521T2 (de) Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen
DE59606486D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69611815T2 (de) Verfahren zur Herstellung von Mischungen aus Polydiorganosiloxanen und Silica
DE69626682T2 (de) Verfahren zur herstellung von guanidinderivaten, zwischenprodukte dafür und ihre herstellung
DE59603431D1 (de) Verfahren zur herstellung von organisch modifizierten aerogelen und deren verwendung
DE59606485D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE59606489D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE59500393D1 (de) Verfahren zur Herstellung von Cyclopropylalkylketonen und 4,5-Dihydroalkylfuranen
DE69903880T2 (de) Oxidationskatalysator-System und dessen Verwendung zur Herstellung von Ketoisophoron
DE59606616D1 (de) Dicarbonsäurederivate und ihre Verwendung zur Herstellung von Poly-o-hydroxyamiden oder Poly-o-mercaptoamiden
DE69627908D1 (de) Flüssiges Zusatzmedium zur Anreicherung von natürlichen und chemischen Düngemitteln
DE69602802D1 (de) Cyanophenylsulfenyl-Halid und seine Verwendung in Verfahren zur Herstellung von 3-substituiertem Benzoisothiazol
DE69834057D1 (de) Echinocandinderivate, deren herstellung und deren verwendung zur bekämpfung von pilzen
DE69701404T2 (de) Umesterungsverfahren zur Herstellung von Dihydromyrcenol und Myrcenol
DE59606488D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69602788D1 (de) Monocarbonate, ihre Anwendung und Verfahren zur Herstellung von Monocarbonaten enthaltenden Kompositionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee